This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Granholm, N. A. Articles by Cavallo, T. Search for Related Content PubMed Articles by Granholm, N. A. Articles by Cavallo, T. Social Bookmarking                   What's this?

Autoimmunity, Polyclonal B-Cell Activation and Infection

Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA

Tito Cavallo

Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA

It is widely believed that autoimmunity is an integral part of the immune system, and that genetic, immunologic, hormonal, environmental and other factors contribute to the pathogenesis of autoimmune disease. Thus, autoimmune disease may represent an abnormal expression of immune functions instead of loss of tolerance to self, and it can be organ specific or systemic in its manifestations. We review the various factors that contribute to the development of autoimmune disease; we also review the mechanisms of polyclonal B-cell activation, with emphasis on the role of infectious agents. We consider systemic lupus erythematosus in humans and in experimental animals as prototypic autoimmune disease, and we summarize data to indicate that polyclonal B-cell activation is central to the pathogenesis of systemic autoimmune disease. The effect of polyclonal B-cell activation, brought about by injections of a B-cell activator - lipopolysaccharide from Gram-negative bacteria—is sufficient to cause autoimmune disease in an immunologically normal host. In fact, autoimmune disease can be arrested if excessive polyclonal B-cell activation is suppressed; alternatively, autoimmune disease can be exacerbated if polyclonal B-cell activation is enhanced. We explore the mechanism of tissue injury when autoimmune disease is induced or exacerbated, and we consider the pathogenic roles of autoantibodies, immune complexes, complement, the blood cell carrier system, and the mononuclear phagocyte system. Although polyclonal B-cell activation may be the mechanism whereby various factors can cause or exacerbate systemic autoimmune disease, polyclonal B-cell activation may cause autoimmune disease on its own.

Key Words: Infectious agents • Immune complexes • Mononuclear phagocyte system • Polyclonal B-cell activation • Systemic lupus erythematosus

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. L. Montes, E. V. Acosta-Rodriguez, M. C. Merino, D. A. Bermejo, and A. Gruppi Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host? J. Leukoc. Biol., November 1, 2007; 82(5): 1027 - 1032. [Abstract] [Full Text] [PDF]

				J. S. Levine, R. Subang, S. H. Nasr, S. Fournier, G. Lajoie, J. Wither, and J. Rauch Immunization with an Apoptotic Cell-Binding Protein Recapitulates the Nephritis and Sequential Autoantibody Emergence of Systemic Lupus Erythematosus J. Immunol., November 1, 2006; 177(9): 6504 - 6516. [Abstract] [Full Text] [PDF]

				H. Jin, R. Carrio, A. Yu, and T. R. Malek Distinct Activation Signals Determine whether IL-21 Induces B Cell Costimulation, Growth Arrest, or Bim-Dependent Apoptosis J. Immunol., July 1, 2004; 173(1): 657 - 665. [Abstract] [Full Text] [PDF]

				T. G. Phan, M. Amesbury, S. Gardam, J. Crosbie, J. Hasbold, P. D. Hodgkin, A. Basten, and R. Brink B Cell Receptor-independent Stimuli Trigger Immunoglobulin (Ig) Class Switch Recombination and Production of IgG Autoantibodies by Anergic Self-Reactive B Cells J. Exp. Med., April 7, 2003; 197(7): 845 - 860. [Abstract] [Full Text] [PDF]

				H. S. Jethwa, S. H. Clarke, Y. Itoh-Lindstrom, R. J. Falk, J. C. Jennette, and P. H. Nachman Restriction in V{kappa} Gene Use and Antigen Selection in Anti-Myeloperoxidase Response in Mice J. Immunol., October 1, 2000; 165(7): 3890 - 3897. [Abstract] [Full Text] [PDF]

				N. Granholm and T. Cavallo Enhancement of renal disease in BXSB lupus prone mice after prior exposure to bacterial lipopolysaccharide Lupus, October 1, 1995; 4(5): 339 - 347. [Abstract] [PDF]